EBV-TCR-T（YT-E-001） for Patients With EBV-positive Recurrent or Metastatic NPC Patients

Condition:   Nasopharyngeal Carcinoma
Intervention:   Biological: EBV-TCR-T (YT-E001) cells
Sponsors:   Fujian Cancer Hospital;   China Immunotech Co., Ltd.
Not yet recruiting

https://ift.tt/2oe2VaQ